• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二氢嘧啶酮(ψ)钙通道阻滞剂的起源:构效关系及其他效应的最新进展

Genesis of dihydropyrimidinone(psi) calcium channel blockers: recent progress in structure-activity relationships and other effects.

作者信息

Singh K, Arora D, Singh K, Singh S

机构信息

Organic Synthesis Laboratory, Department of Applied Chemical Sciences & Technology, Guru Nanak Dev University, Amritsar - 143 005, India.

出版信息

Mini Rev Med Chem. 2009 Jan;9(1):95-106. doi: 10.2174/138955709787001686.

DOI:10.2174/138955709787001686
PMID:19149663
Abstract

In the armamentarium of calcium channel blockers appropriately functionalized 3,4-dihydropyrimidin-2(1H)-ones have received considerable attention in recent past owing to their structural similarity with 1,4-dihydropyridine based drugs. In this review, we highlight detailed investigations in the calcium channel blocking and other activities of this category of compounds as well as trace their genesis from 1,4-dihydropyridine based drugs.

摘要

在钙通道阻滞剂的药物库中,适当功能化的3,4-二氢嘧啶-2(1H)-酮类化合物由于其与基于1,4-二氢吡啶的药物结构相似,在最近受到了相当大的关注。在这篇综述中,我们重点介绍了对这类化合物的钙通道阻滞及其他活性的详细研究,以及追溯它们从基于1,4-二氢吡啶的药物衍生而来的过程。

相似文献

1
Genesis of dihydropyrimidinone(psi) calcium channel blockers: recent progress in structure-activity relationships and other effects.二氢嘧啶酮(ψ)钙通道阻滞剂的起源:构效关系及其他效应的最新进展
Mini Rev Med Chem. 2009 Jan;9(1):95-106. doi: 10.2174/138955709787001686.
2
The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities.新一代带有4-苯氧基丙醇胺的二氢吡啶类钙阻滞剂具有α/β肾上腺素能受体拮抗作用和长效降压活性。
Bioorg Med Chem. 2002 Mar;10(3):719-30. doi: 10.1016/s0968-0896(01)00318-2.
3
The structure-activity relationship study on 2-, 5-, and 6-position of the water soluble 1,4-dihydropyridine derivatives blocking N-type calcium channels.水溶性1,4 - 二氢吡啶衍生物2 -、5 - 和6 - 位阻断N型钙通道的构效关系研究
Bioorg Med Chem Lett. 2008 Sep 1;18(17):4813-6. doi: 10.1016/j.bmcl.2008.07.096. Epub 2008 Jul 27.
4
The 1,4-dihydropyridine nucleus: a pharmacophoric template part 1. Actions at ion channels.1,4 - 二氢吡啶核:一种药效团模板 第1部分。对离子通道的作用。
Mini Rev Med Chem. 2003 May;3(3):215-23. doi: 10.2174/1389557033488141.
5
Quantitative structure-activity relationship study of recently synthesized 1,4-dihydropyridine calcium channel antagonists. Application of the Hansch analysis method.近期合成的1,4-二氢吡啶类钙通道拮抗剂的定量构效关系研究。汉施分析法的应用。
Arch Pharm (Weinheim). 2002 Dec;335(10):472-80. doi: 10.1002/ardp.200290001.
6
Discovery of alpha 1a-adrenergic receptor antagonists based on the L-type Ca2+ channel antagonist niguldipine.基于L型钙通道拮抗剂尼群地平发现α1a-肾上腺素能受体拮抗剂
J Med Chem. 1995 May 12;38(10):1579-81. doi: 10.1021/jm00010a001.
7
Structure-activity relationship study of 1,4-dihydropyridine derivatives blocking N-type calcium channels.1,4-二氢吡啶衍生物阻断N型钙通道的构效关系研究
Bioorg Med Chem Lett. 2006 Feb 15;16(4):798-802. doi: 10.1016/j.bmcl.2005.11.021. Epub 2005 Nov 23.
8
[Calcium antagonists of the dihydropyridine type: pharmaceutical chemistry and molecular pharmacology].[二氢吡啶类钙拮抗剂:药物化学与分子药理学]
Pharm Unserer Zeit. 1995 Jun;24(3):137-53. doi: 10.1002/pauz.19950240310.
9
Integrated analysis on the physicochemical properties of dihydropyridine calcium channel blockers in grapefruit juice interactions.柚汁与二氢吡啶类钙通道阻滞剂相互作用的理化性质综合分析。
Curr Pharm Biotechnol. 2012 Jul;13(9):1705-17. doi: 10.2174/138920112800958878.
10
QSAR, diagnostic statistics and molecular modelling of 1,4-dihydropyridine calcium antagonists: a difficult road ahead.
Drug Des Discov. 1992 Jul;8(4):273-89.

引用本文的文献

1
Biginelli dihydropyrimidines and their acetylated derivatives as L-/T-type calcium channel blockers: Synthesis, enantioseparation, and molecular modeling studies.作为L型/T型钙通道阻滞剂的Biginelli二氢嘧啶及其乙酰化衍生物:合成、对映体拆分及分子模拟研究
Arch Pharm (Weinheim). 2025 Mar;358(3):e2400584. doi: 10.1002/ardp.202400584.
2
Updates on Intrinsic Medicinal Chemistry of 1,4-dihydropyridines, Perspectives on Synthesis and Pharmacokinetics of Novel 1,4-dihydropyrimidines as Calcium Channel Blockers: Clinical Pharmacology.1,4 - 二氢吡啶的内在药物化学进展,新型1,4 - 二氢嘧啶作为钙通道阻滞剂的合成与药代动力学展望:临床药理学
Curr Top Med Chem. 2025 Jan 1. doi: 10.2174/0115680266323908241114064318.
3
Synthesis of Dihydropyrimidines: Isosteres of Nifedipine and Evaluation of Their Calcium Channel Blocking Efficiency.
二氢嘧啶的合成:硝苯地平的等排体及其钙通道阻滞效率的评价。
Molecules. 2023 Jan 12;28(2):784. doi: 10.3390/molecules28020784.
4
Magnetic core-shell Carrageenan moss/FeO: a polysaccharide-based metallic nanoparticles for synthesis of pyrimidinone derivatives via Biginelli reaction.磁性核壳角叉菜苔藓/FeO:一种用于通过Biginelli反应合成嘧啶酮衍生物的多糖基金属纳米颗粒。
Chem Cent J. 2018 Oct 27;12(1):108. doi: 10.1186/s13065-018-0477-3.
5
Secondary amine-initiated three-component synthesis of 3,4-dihydropyrimidinones and thiones involving alkynes, aldehydes and thiourea/urea.二级胺引发的炔、醛和硫脲/脲的三组分反应合成 3,4-二氢嘧啶酮和硫酮。
Beilstein J Org Chem. 2014 Jan 29;10:287-92. doi: 10.3762/bjoc.10.25. eCollection 2014.
6
An efficacious protocol for C-4 substituted 3,4-dihydropyrimidinones. Synthesis and calcium channel binding studies.一种用于C-4取代的3,4-二氢嘧啶酮的有效方案。合成及钙通道结合研究。
European J Org Chem. 2009 Jul 1;2009(19). doi: 10.1002/ejoc.200900208.
7
Raman spectroscopy as a tool for monitoring mesoscale continuous-flow organic synthesis: Equipment interface and assessment in four medicinally-relevant reactions.拉曼光谱作为监测中尺度连续流动有机合成的工具:在四种药用相关反应中的设备接口和评估。
Beilstein J Org Chem. 2013 Sep 11;9:1843-52. doi: 10.3762/bjoc.9.215. eCollection 2013.
8
Cationic dirhodium carboxylate-catalyzed synthesis of dihydropyrimidones from propargyl ureas.羧酸铑(II)催化下由炔丙基脲合成二氢嘧啶酮
Tetrahedron. 2013 Jul 8;69(27-28):5744-5750. doi: 10.1016/j.tet.2013.04.071.
9
Biginelli reaction catalyzed by copper nanoparticles.铜纳米粒子催化的 Biginelli 反应。
PLoS One. 2012;7(8):e43078. doi: 10.1371/journal.pone.0043078. Epub 2012 Aug 17.
10
Enantioselective rhodium-catalyzed [4+2] cycloaddition of α,β-unsaturated imines and isocyanates.手性铑催化的α,β-不饱和亚胺和异氰酸酯的[4+2]环加成反应。
J Am Chem Soc. 2011 Apr 6;133(13):4785-7. doi: 10.1021/ja200766k. Epub 2011 Mar 14.